David Goone

About David Goone

David Goone sits on the board of Rua Diagnostics, which is developing a portable breath test for disease. He was CEO and a board member of tZERO Group from 2022 until September 2025.

Before tZERO he spent two decades at Intercontinental Exchange (ICE), which he joined in 2001. He was senior vice president for business development and sales, then chief strategy officer from 2006 to 2022, and later an advisor to the CEO. He represented ICE on the boards of DTCC, the Options Clearing Corporation and the National Futures Association. He was also vice chairman of CETIP until its merger with B3. Earlier he was managing director for product development and sales at the Chicago Mercantile Exchange. Before that he was a vice president at Indosuez Carr Futures from 1989 to 1992, and he worked at Chase Manhattan Bank.

Experience

This experience comes from official bios and from SEC filings. For roles taken from filings, the years are when the filings name David Goone in the role, so the role may have started earlier or lasted longer.

Rua Diagnostics Inc. Current

Board Member

2026 – Present · Westbury, NY

Develops a breath test that uses gas chromatography and machine learning to look for disease.

TI

tZERO Group, Inc.

Chief Executive Officer (2022 – 2025)

Board member

2022 – 2025

Options Clearing Corp.

Director

2014 – 2023 · Chicago, IL

Clears equity derivatives and provides options education to investors and financial professionals.

II

Intercontinental Exchange, Inc.

Chief Strategic Officer

Advisor to the Chief Executive Officer (From 2022)

Chief Strategy Officer (2006 – 2022)

Senior Vice President, Business Development and Sales

2006 – 2022 · Public company (ICE)

II

Intercontinentalexchange Inc.

Sr VP, Chief Strategic Officer

2006 – 2013 · Public company (ICE)

IF

Indosuez Carr Futures

Vice President

1989 – 1992

CE

Chicago Mercantile Exchange

Managing Director, Product Development and Sales

CB

Chase Manhattan Bank

DD

Depository Trust & Clearing Corporation (DTCC)

Board member

NN

National Futures Association (NFA)

Board member

CB

CETIP S.A. (Vice Chairman, until its merger with B3)

Board member

Key Colleagues at Startups

The people David Goone works with at each company, as listed on that company's latest Form D.

Rua Diagnostics Inc. · Form D, May 27, 2026

Peter Michalos

Board Member

Jillian Levovitz

Chief Executive Officer and President

Kenneth Orr

Board Co-Chair

Jonathan Orr

Board Chair

David Goone in the News

• Oct 24, 2025·Markets MediatZERO Resets Vision, Focuses on Partnerships
• Jul 24, 2024·Haute LivingFinancial Future: Executive Interview With tZERO's David Goone, Alan Konevsky, And Ryan Zega
• Feb 23, 2022·Ledger InsightsNYSE parent invests in security token firm tZERO

Sources

1. SECRua Diagnostics Inc. Form D, filed May 27, 2026
2. SECOptions Clearing Corp. Form D, filed Mar 24, 2023
3. SECForms 3, 4 and 5 filed by David Goone (SEC filer 1343869)
4. Press releaseIntercontinental Exchange, Feb 22, 2022: strategic investment in tZERO, David Goone to become CEO
5. SEC filingIntercontinental Exchange 8-K, Feb 22, 2022 (Goone to retire as Chief Strategy Officer effective March 15, 2022)
6. SEC filingIntercontinental Exchange 8-K/A, Mar 17, 2022 (Advisor to the CEO from March 16, 2022)
7. SEC filingIntercontinentalexchange S-1/A, July 2006 (biography: Chief Strategic Officer since May 2006, earlier roles)
8. SEC filingIntercontinentalexchange S-1/A, November 2005 (biography: Senior Vice President, Business Development and Sales)
9. Company sitetZERO, Sept 5, 2025: Alan Konevsky succeeds David Goone, who previously served as CEO and board member
10. Company sitetZERO news page, Feb 22, 2022: appointment of ICE executive David Goone as new Chief Executive Officer